HB 413 In Committee
Health Care - As introduced, authorizes a patient with a severe chronic disease or terminal illness to access, and a physician to recommend, investigational stem cell treatment; requires the commissioner of health to promulgate rules to, among other things, list the medical conditions that constitute a qualifying severe chronic disease or terminal illness. - Amends TCA Title 53; Title 63 and Title 68.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Mar 18, 2026 · House
Taken off notice for cal in s/c Health Subcommittee of Health Committee
Mar 11, 2026 · House
Placed on s/c cal Health Subcommittee for 3/18/2026
Mar 11, 2026 · House
Action Def. in s/c Health Subcommittee to 3/18/2026
Mar 4, 2026 · House
Placed on s/c cal Health Subcommittee for 3/11/2026
Mar 4, 2026 · House
Action Def. in s/c Health Subcommittee to 3/11/2026
Feb 25, 2026 · House
Placed on s/c cal Health Subcommittee for 3/4/2026
Feb 5, 2025 · House
Assigned to s/c Health Subcommittee
Feb 5, 2025 · House
P2C, ref. to Health Committee- Government Operations for Review
Feb 3, 2025 · House
Intro., P1C.
Jan 28, 2025 · House
Filed for introduction